Circadian changes in carrageenin-induced edema: the anti-inflammatory effect and bioavailability of phenylbutazone in rats.
The circadian variations in paw-edema produced by carrageenin and the anti-inflammatory effect of phenylbutazone were studied, in rats kept under a 12 light-12 dark regimen, in comparison with the variations of plasma phenylbutazone and oxyphenbutazone levels. When the experiment was performed during the light span (08.00 and 14.00 h), the rats were highly sensitive to the phlogistic effect of carrageenin, the plasma levels of phenylbutazone and oxyphenbutazone were lower, and the anti-inflammatory effect of phenylbutazone, weaker. Opposite results were obtained when the experiment was performed during the dark span (02.00 and 20.00 h). The results indicate that the chronoeffectiveness of phenylbutazone is influenced by both its chronokinetics and the chronesthesy of the biosystem involved.
D000818:Animals; D000893:Anti-Inflammatory Agents; D001682:Biological Availability; D002351:Carrageenan; D002940:Circadian Rhythm; D004487:Edema / Q000139:chemically induced / Q000378:metabolism / Q000503:physiopathology*; D007700:Kinetics; D008297:Male; D010113:Oxyphenbutazone / Q000097:blood; D010653:Phenylbutazone / Q000097:blood / Q000494:pharmacology*; D051381:Rats; D011919:Rats, Inbred Strains
D000893:Anti-Inflammatory Agents; D002351:Carrageenan; D010653:Phenylbutazone; D010113:Oxyphenbutazone